Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1962 1
1963 1
1964 2
1965 4
1966 3
1967 8
1968 4
1969 3
1970 7
1971 1
1973 1
1975 1
1976 3
1977 9
1978 17
1979 12
1980 14
1981 15
1982 16
1983 18
1984 20
1985 28
1986 22
1987 42
1988 27
1989 32
1990 54
1991 51
1992 36
1993 32
1994 46
1995 38
1996 34
1997 66
1998 67
1999 78
2000 64
2001 81
2002 95
2003 80
2004 81
2005 100
2006 105
2007 101
2008 102
2009 101
2010 108
2011 115
2012 126
2013 125
2014 138
2015 136
2016 149
2017 164
2018 146
2019 166
2020 178
2021 186
2022 141
Text availability
Article attribute
Article type
Publication date

Search Results

3,311 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial.
Rosenstock J, Wysham C, Frías JP, Kaneko S, Lee CJ, Fernández Landó L, Mao H, Cui X, Karanikas CA, Thieu VT. Rosenstock J, et al. Among authors: kaneko s. Lancet. 2021 Jul 10;398(10295):143-155. doi: 10.1016/S0140-6736(21)01324-6. Epub 2021 Jun 27. Lancet. 2021. PMID: 34186022 Clinical Trial.
Telomerase-Targeted Cancer Immunotherapy.
Mizukoshi E, Kaneko S. Mizukoshi E, et al. Among authors: kaneko s. Int J Mol Sci. 2019 Apr 12;20(8):1823. doi: 10.3390/ijms20081823. Int J Mol Sci. 2019. PMID: 31013796 Free PMC article. Review.
Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma.
Finn RS, Ikeda M, Zhu AX, Sung MW, Baron AD, Kudo M, Okusaka T, Kobayashi M, Kumada H, Kaneko S, Pracht M, Mamontov K, Meyer T, Kubota T, Dutcus CE, Saito K, Siegel AB, Dubrovsky L, Mody K, Llovet JM. Finn RS, et al. Among authors: kaneko s. J Clin Oncol. 2020 Sep 10;38(26):2960-2970. doi: 10.1200/JCO.20.00808. Epub 2020 Jul 27. J Clin Oncol. 2020. PMID: 32716739 Free PMC article. Clinical Trial.
Notch Signaling and Liver Cancer.
Kawaguchi K, Kaneko S. Kawaguchi K, et al. Among authors: kaneko s. Adv Exp Med Biol. 2021;1287:69-80. doi: 10.1007/978-3-030-55031-8_6. Adv Exp Med Biol. 2021. PMID: 33034027 Review.
Capturing human trophoblast development with naive pluripotent stem cells in vitro.
Io S, Kabata M, Iemura Y, Semi K, Morone N, Minagawa A, Wang B, Okamoto I, Nakamura T, Kojima Y, Iwatani C, Tsuchiya H, Kaswandy B, Kondoh E, Kaneko S, Woltjen K, Saitou M, Yamamoto T, Mandai M, Takashima Y. Io S, et al. Among authors: kaneko s. Cell Stem Cell. 2021 Jun 3;28(6):1023-1039.e13. doi: 10.1016/j.stem.2021.03.013. Epub 2021 Apr 7. Cell Stem Cell. 2021. PMID: 33831365 Free article.
A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy.
Iriguchi S, Yasui Y, Kawai Y, Arima S, Kunitomo M, Sato T, Ueda T, Minagawa A, Mishima Y, Yanagawa N, Baba Y, Miyake Y, Nakayama K, Takiguchi M, Shinohara T, Nakatsura T, Yasukawa M, Kassai Y, Hayashi A, Kaneko S. Iriguchi S, et al. Among authors: kaneko s. Nat Commun. 2021 Jan 18;12(1):430. doi: 10.1038/s41467-020-20658-3. Nat Commun. 2021. PMID: 33462228 Free PMC article.
Androgen conspires with the CD8+ T cell exhaustion program and contributes to sex bias in cancer.
Kwon H, Schafer JM, Song NJ, Kaneko S, Li A, Xiao T, Ma A, Allen C, Das K, Zhou L, Riesenberg B, Chang Y, Weltge P, Velegraki M, Oh DY, Fong L, Ma Q, Sundi D, Chung D, Li X, Li Z. Kwon H, et al. Among authors: kaneko s. Sci Immunol. 2022 Jul;7(73):eabq2630. doi: 10.1126/sciimmunol.abq2630. Epub 2022 Jul 1. Sci Immunol. 2022. PMID: 35420889 Free PMC article.
MicroRNA expression profiling in acute kidney injury.
Aomatsu A, Kaneko S, Yanai K, Ishii H, Ito K, Hirai K, Ookawara S, Kobayashi Y, Sanui M, Morishita Y. Aomatsu A, et al. Among authors: kaneko s. Transl Res. 2022 Jun;244:1-31. doi: 10.1016/j.trsl.2021.11.010. Epub 2021 Dec 4. Transl Res. 2022. PMID: 34871811 Free article.
Non-clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell-derived anti-glypican-3 chimeric antigen receptor-expressing natural killer/innate lymphoid cells.
Ueda T, Kumagai A, Iriguchi S, Yasui Y, Miyasaka T, Nakagoshi K, Nakane K, Saito K, Takahashi M, Sasaki A, Yoshida S, Takasu N, Seno H, Uemura Y, Tamada K, Nakatsura T, Kaneko S. Ueda T, et al. Among authors: kaneko s. Cancer Sci. 2020 May;111(5):1478-1490. doi: 10.1111/cas.14374. Epub 2020 Mar 31. Cancer Sci. 2020. PMID: 32133731 Free PMC article.
3,311 results